O. Akbulut Et Al. , "Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer," Experimental and Molecular Therapeutics , 2019
Akbulut, O. Et Al. 2019. Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer. Experimental and Molecular Therapeutics .
Akbulut, O., LENGERLİ, D., Saatci, O., Duman, E., Seker, U., ÇALIŞKAN, B., ... BANOĞLU, E.(2019). Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer . Experimental and Molecular Therapeutics
Akbulut, Ozge Et Al. "Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer," Experimental and Molecular Therapeutics, 2019
Akbulut, Ozge Et Al. "Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer." Experimental and Molecular Therapeutics , 2019
Akbulut, O. Et Al. (2019) . "Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer." Experimental and Molecular Therapeutics .
@conferencepaper{conferencepaper, author={Ozge Akbulut Et Al. }, title={Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer}, congress name={Experimental and Molecular Therapeutics}, city={}, country={}, year={2019}}